Categories: 心血管病未分类

Intensive Glucose Control Has Cardiovascular Benefits强化血糖控制有益于心血管

A nearly 10 years of extended follow-up of a randomized study in the US revealed that patients with type 2 diabetes who had been assigned to intensive glucose control for 5.6 years had 8.6 fewer major cardiovascular events per 1000 person-years than those assigned to standard therapy, but not mortality. The difference in glycated hemoglobin levels between the intensive-therapy group and the standard-therapy group averaged 1.5 percentage points during the trial (median level, 6.9% vs. 8.4%) and declined to 0.2 to 0.3 percentage points by 3 years after the trial ended. Over a median follow-up of 9.8 years, the intensive-therapy group had a significantly lower risk of the primary outcome than did the standard-therapy group, but did not have reduced cardiovascular and total mortality. This is the first time cardiovascular benefit has been shown for more intensive glucose control. The benefits need to be weighed against potential harm due to aggressive management, such as weight gain and hypoglycemia. It is known that intensive glycemic control is important for microvascular disease. Source: http://www.nejm.org/对美国一个随机研究近10年的延长随访发现,2型糖尿病患者经5.6年的强化血糖控制,每1000人中主要心血管事件比那些给予标准疗法者少8.6例,而非死亡率。试验期间强化治疗组和标准治疗组之间的糖化血红蛋白水平差异平均1.5个百分点(中位数6.9%和8.4%),试验结束后3年下降到0.2至0.3个百分点。在中位随访9.8年间,强化治疗组比标准治疗组的主要预后风险显著降低,但并没有减少心血管病和总死亡率。这还是第一次证明强化血糖控制有益于心血管。强化血糖控制的益处需要与其潜在的危害相权衡,如体重增加和低血糖。已知强化血糖控制对微血管病很重要。来源:http://www.nejm.org/

hyangiu

近期博文

4:3间歇性禁食减肥效果优于每日热量限制

一项美国随机临床试验发现,对于…

3 天 ago

新型降糖药对老年二型糖尿病患者心血管病的效果比较

一项丹麦全国性队列研究提供的真…

1 周 ago

非手术与非介入疗法对腰痛的疗效

基于安慰剂对照的随机试验,一项…

2 周 ago

服用他汀类药物与肝癌及肝病进展风险降低有关

一项美国队列研究提示,服用他汀…

2 周 ago

颈动脉斑块的临床意义及其与年龄和性别的关系

一项美国队列研究提示,在没有临…

3 周 ago

用植物油取代黄油可提高生存率

一项基于美国人群的前瞻性队列研…

4 周 ago

This website uses cookies.